Engineering DNA Vaccines that Include Plant Virus Coat Proteins

Biotechnology and Genetic Engineering Reviews

Volumn 20, Issue 1, 2003, Pages 101-116

  Savelyeva, Natalia ^a   Zhu, Delin ^a   Stevenson, Freda K ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUSES;

COAT PROTEINS; DNA VACCINE; PLANT VIRUS;

PROTEINS;

CANCER VACCINE; CD4 ANTIGEN; COAT PROTEIN; DNA FUSION VACCINE; DNA VACCINE; ID FUSION VACCINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; GENETIC ENGINEERING; IMMUNE RESPONSE; LYMPHOMA; MYELOMA; PLANT VIRUS; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN FOLDING; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 1242269381     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.1080/02648725.2003.10648039     Document Type: Article

References (42)

1. Beatty, G. and Paterson, Y. (2001). IFN-gamma-dependent inhibition of tumour angio-gcnesis by tumour-infiltrating CD4+T cells requires tumourresponsiveness to IFN-gamma. Journal of Immunology 166,2276-2282.
2. BIRAGYN, A., TANI, K., GRIMM, M.C., WEEKS, S. and KWAK, L.W. (1999). Genetic fusion of chemokines to a self tumour antigen induces protective, T cell dependent antitumour immunity. Nature Biotechnology 17, 253-258.
3. Bot, A., Stan, A.C., Inaba, K., Steinman, R. and Bona, C. (2000). Dendritic cells at a DNA vaccination site express the encoded influenza nucleoprotein and prime MHC class I-restricted cytolytic lymphocytes upon adoptive transfer. International Immunology 12, 825-832.
4. Brennan, F.R., Jones, T.D., Longstaff, M. et al. (1999). Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine 17,1846-1857.
5. Campbell, MJ., Carroll, W., Kon, S. et al. (1987). Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumour-derived immunoglobulin M and its molecular subunits. Journal of Immunology 139, 2825-2833.
6. CONDON, C., WATKINS, S.C., CELLUZZI, C.M., THOMPSON, K. and FALO, L.D., JR. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nature Medicine 2, 1122-1128.
7. Conry, R.M., Widera, G., LoBuguo, A.F. et al. (1996). Selected strategies to augment polynucleotide immunization. Gene Therapy 3, 67-74.
8. Dalsgaard, K., UTTENTHAL, A., JONES, T.D. et al. (1996). Plant-derived vaccine protects target animals against a viral disease. Nature Biotechnology 15, 248-252.
9. Dorothee, G., Vergnon, I., Menez, J. et al. (2002). Tumour-infiltrating CD4+T lymphocytes express AP02 ligand (AP02L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on AP02L/TRAIL expression and-mediated cytotoxicity. Journal of Immunology 169, 809-817.
10. FELTQUATE, D.M., HEANEY, S., WEBSTER, R.G. and ROBINSON, H.L. (1997). Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. Journal of Immunology 158, 2278-2284.
11. FORCONI, F., KING, C.A., SAHOTA, S.S., KENNAWAY, C.K., RUSSELL, N.H. and STEVENSON, F.K. (2002). Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses. Immunology 107,39-45.
12. Fu, T.M., Ulmer, J.B., CAULFIELD, M.J. et al. (1997). Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen-presenting cells and evidence for antigen transfer from myocytes. Molecular Medicine 3, 362-371.
13. GEORGE, A.J., Tutt, A.L. and Stevenson, F.K. (1987). Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. Journal of Immunology 138,628-634.
14. Gerloni, m., Xiong, S., Mukerjee, S., Schoenberger, S.P., Croft, m. and Zanetti, M. (2000). Functional cooperation between T helper cell determinants. Proceedings of the National Academy of Sciences of the United States of America 97, 13269-13274.
15. Hawkins, R.E., Zhu, D., Ovecka, M. et al. (1994). Idiotypic vaccination against human B cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 83, 3279-3288.
16. Hemmi, H., TAKEUCHI, O., Kawai, T. et al. (2000). A Toil-like receptor recognizes bacterial DNA. Nature 408,740-745.
17. Hsu, FJ., Caspar, C.B., Czerwinski, D. et al. (1997). Tumour-specific idiotype vaccines in the treatment of patients with B cell lymphoma-long-term results of a clinical trial. Blood 89,3129-3135.
18. Hung, K., Hayashi, R., Lafond-Walker, A. et al. (1998). The central role of CD4+ T cells in the antitumour immune response. Journal of Experimental Medicine 188, 2357-2368.
19. Ju, S.T., Cui, H., Panka, D.J., Ettinger, R. and Marshak-Rothstein, A. (1994). Participation of target Fas protein in apoptosis pathway induced by CD4+ Thl and CD8+ cytotoxic T cells. Proceedings of the National Academy of Sciences of the United States of America 91, 4185-4189.
20. Kaplan, M.J., Ray, D., Mo, R.R., Yung, R.L. and Richardson, B.C. (2000). TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. Journal of Immunology 164, 2897-2904.
21. King, C.A., Spellerberg, M.B., Zhu, D. et al (1998). DNA vaccines with single chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nature Medicine 4, 1281-1286.
22. Krieg, A.M. (2002). CpG motifs in bacterial DNA and their immune effects. Annual Review of Immunology 20, 709-760.
23. Krieg, A.M., Yl, A.K., Matson, S. et al. (1995). CpG motifs in bacterial DNA trigger direct B cell activation. Nature 374, 546-549.
24. Marusic, C., Rizza, P., Lattanzi, L. et al. (2001). Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. Journal of Virology 75, 8434-8439.
25. McInerney, T.L., Brennan, F.R., Jones, T.D. and Dimmock, N.J. (1999). Analysis of the ability of five adjuvants to enhance immmune responses to a chimeric plant virus displaying an HIV-1 peptide. Vaccine 17, 1359-1368.
26. Mumberg, D., Monach, P.A., Wanderling, S. et al. (1999). CD4+T cells eliminate MHC class II-negative cancer cells in vivo by indirect effect of IFN-y. Proceedings of the National Academy of Sciences of the United States of America 96, 8633-8638.
27. PARDOLL, D.M. and TOPALIAN, S.L. (1998). The role of CD4+ T cell responses in antitumour immunity. Current Opinion in Immunology 10, 588-594.
28. POLO, J.M., Gardner, J.P., Jl, Y. et al. (2000). Alphavirus DNA and particle replicons for vaccines and gene therapy. Developmental Biology (Basel) 104, 181-185.
29. Porta, C. and Lomonossoff, G.P. (1998). Scope for using plant viruses to present epitopes from animal pathogens. Reviews in Medical Virology 8, 25-41.
30. Qin, Z. and Blankenstein, T. (2000). CD4+T cell-mediated tumour rejection involves inhibition of angiogenesis that is dependent on IFN-y receptor expression by non-haematopoietic cells. Immunity 12,677-686.
31. Rice, J., Elliott, T., Buchan, S. and Stevenson, F.K. (2001). DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. Journal of Immunology 167, 1558-1565.
32. Rice, j., Buchan, S. and Stevenson, F.K. (2002). Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumour antigen. Journal of Immunology 169, 3908-3913.
33. Santa Cruz, S., Chapman, S., Roberts, A.G., Roberts, I.M., Prior, D.A.M. and Oparka, K.J. (1996). Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proceedings ofthe National Academy of Sciences of the United States of America 93, 6286-6290.
34. Savelyeva, N., Munday, R., Spellerberg, M.B., Lomonossoff, G.P. and Stevenson, F.K. (2001). Plant viral genes in DNA vaccines activate linked CD4+ T cell mediated immunity against B cell malignancies. Nature Biotechnology 19, 760-764.
35. Smolenska, L., Roberts, I.M., Learmonth, D. et al. (1998). Production of a functional single chain antibody attached to the surface of a plant virus. FEBS Letters 441, 379-382.
36. Spellerberg, M.B., Zhu, D., Thompsett, A., King, C.A., Hamblin, T.J. and Stevenson, F.K. (1997). DNA vaccines against lymphoma. Promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C. Journal of Immunology 159, 1885-1892.
37. Spets, H., Georgii-Hemming, P., Siljason, J., Nilsson, K. and Jernberg-Wiklund, H. (1998). Fas/APO-i (CD95)-mediated apoptosis is activated by interferon-gamma and interferon-in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines. Blood 92,2914-2923.
38. SyrenGelas, A.D., Chen, T.T. and Levy, R. (1996). DNA immunization induces protective immunity against B cell lymphoma. Nature Medicine 2, 1038-1041.
39. TANG, D.C., DEVIT, M. and JOHNSTON, S.A. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.
40. Thomas, W.D. and Hersey, P. (1998). TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. Journal of Immunology 161, 2195-2200.
41. Turpen, T.H., Reinl, S.J., Charoenvit, U., Hoffman, S.L., Fallarme, V. and Grill, L.K. (1995). Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Bio/Technology 13, 53-57.
42. Zhu, D., Rice, J., Savelyeva, N. and Stevenson, F.K. (2001). DNA fusion vaccines against B ceil tumours. Trends in Molecular Medicine 7, 566-572.